Maria Teresa Sandri - Concepedia

Author

Maria Teresa Sandri

Also Known As

M Sandri, M T Sandri, M-T Sandri, M. Sandri, M. T. Sandri, M. Teresa Sandri, M.T. Sandri, MT Sandri, MT. Sandri, Maria Sandri

243

Publications

15.3K

Citations

H-Index

148

Concepts

All Affiliations

European Institute of Oncology University of Milan Istituti di Ricovero e Cura a Carattere Scientifico Humanitas University IRCCS Humanitas Research Hospital

About

Maria Teresa Sandri is an author at European Institute of Oncology specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	57	5.5K
2	Public Health	15	17	673
3	Health Sciences	6	6	163
4	Engineering	1	1	12
5	Social Sciences	1	1	12

Maria Teresa Sandri

109

Publications

13.3K

Citations

H-Index

Page 1

	Year	Citations
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy Corrado Lodigiani, G. Iapichino, Luca Carenzo, Thrombosis Research	2020	2.1K
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition Daniela Cardinale, Alessandro Colombo, Maria Teresa Sandri, Circulation	2006	1K
Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy Daniela Cardinale, Maria Teresa Sandri, Alessandro Colombo, Circulation	2004	927
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines Giuseppe Curigliano, Daniela Cardinale, Thomas Suter, Annals of Oncology Radiation MedicineOncologyRadiation TherapyCardiovascular DiseasePharmacotherapy	2012	845
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data François‐Clément Bidard, Dieter Peeters, Tanja Fehm, The Lancet Oncology Metastatic Breast CancerBreast OncologyClinical ValidityIndividual Patient DataMedicine	2014	815
Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation Daniela Cardinale, Alessandro Colombo, Rosalba Torrisi, Journal of Clinical Oncology	2010	630
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy Daniela Cardinale, Maria Teresa Sandri, Alessandro Martinoni, Journal of the American College of Cardiology Heart FailureLeft Ventricular DysfunctionEarly TroponinHigh-dose ChemotherapyCardiovascular Toxicity	2000	550
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels Marco Colleoni, Andrea Rocca, Maria Teresa Sandri, Annals of Oncology Metastatic Breast CancerOncologyAntitumor ActivityLow-dose Oral MethotrexateBreast Oncology	2002	500
Thyrotoxicosis in patients with COVID-19: the THYRCOV study Andrea Lania, Maria Teresa Sandri, Miriam Cellini, European Journal of Endocrinology	2020	357
Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy Daniela Cardinale, Maria Teresa Sandri, Alessandro Martinoni, Annals of Oncology OncologyPathologyPlasma TroponinBreast CancerCardiovascular Toxicity	2002	308

Page 1